Kiniksa Pharmaceuticals KNSA Declines 484 as Stock Tests Key Support Zone Bitcoin Dips to SixWeek Low as USIran Deal Report Fails to Boost Crypto Sentiment JUNS Q4 2025 Earnings NarrowerThanExpected Loss as Stock Declines Ferraris EV Launch Event Stock Dip May Signal ShortTerm Concern LongTerm Opportunity